UA97875C2 - Фармацевтическое средство для лечения демиелинизирующих заболеваний нервной системы на основе стефаглабрина - Google Patents

Фармацевтическое средство для лечения демиелинизирующих заболеваний нервной системы на основе стефаглабрина

Info

Publication number
UA97875C2
UA97875C2 UAA201008255A UAA201008255A UA97875C2 UA 97875 C2 UA97875 C2 UA 97875C2 UA A201008255 A UAA201008255 A UA A201008255A UA A201008255 A UAA201008255 A UA A201008255A UA 97875 C2 UA97875 C2 UA 97875C2
Authority
UA
Ukraine
Prior art keywords
nervous system
demyelinating diseases
stefaglabrin
pharmaceutical agent
system based
Prior art date
Application number
UAA201008255A
Other languages
English (en)
Ukrainian (uk)
Inventor
Евгений Вениаминович Арзамасцев
Клавдия Игнатьевна Малиновская
Маргарита Ивановна Миронова
Original Assignee
Закритое Акционерное Общество "Биоген Технолоджиз"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Закритое Акционерное Общество "Биоген Технолоджиз" filed Critical Закритое Акционерное Общество "Биоген Технолоджиз"
Publication of UA97875C2 publication Critical patent/UA97875C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Изобретение относится к фармацевтическому средству для лечения демиелинизирующих заболеваний нервной системы, которое содержит стефаглабрина сульфат, которое способствует восстановлению миелиновой оболочки нервного волокна, и к способу лечения демиелинизирующих заболеваний нервной системы.
UAA201008255A 2007-12-06 2008-12-05 Фармацевтическое средство для лечения демиелинизирующих заболеваний нервной системы на основе стефаглабрина UA97875C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2007145037/15A RU2355413C1 (ru) 2007-12-06 2007-12-06 Фармацевтическое средство для лечения демиелинизирующих заболеваний нервной системы, средство, способствующее восстановлению миелиновой оболочки нервного волокна, и способ лечения демиелинизирующих заболеваний нервной системы
PCT/RU2008/000747 WO2009075607A2 (en) 2007-12-06 2008-12-05 Pharmaceutical preparation for treating demyelinating diseases of the nervous system; preparation promoting restoration of the myelin sheath of nerve fibers; and a method for treating demyelinating diseases of the nervous system

Publications (1)

Publication Number Publication Date
UA97875C2 true UA97875C2 (ru) 2012-03-26

Family

ID=40756011

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201008255A UA97875C2 (ru) 2007-12-06 2008-12-05 Фармацевтическое средство для лечения демиелинизирующих заболеваний нервной системы на основе стефаглабрина

Country Status (18)

Country Link
US (2) US8440683B2 (ru)
EP (1) EP2271340B1 (ru)
JP (1) JP5485166B2 (ru)
KR (1) KR20100113505A (ru)
CN (1) CN101888842B (ru)
AT (1) ATE552001T1 (ru)
CA (1) CA2707681C (ru)
CY (1) CY1112818T1 (ru)
DK (1) DK2271340T3 (ru)
EA (1) EA201000786A1 (ru)
ES (1) ES2383315T3 (ru)
HR (1) HRP20120422T1 (ru)
PL (1) PL2271340T3 (ru)
PT (1) PT2271340E (ru)
RU (1) RU2355413C1 (ru)
SI (1) SI2271340T1 (ru)
UA (1) UA97875C2 (ru)
WO (1) WO2009075607A2 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102526648B1 (ko) * 2015-08-21 2023-04-27 삼성전자주식회사 2,5-디히드록시벤젠술폰산을 포함하는 신경세포의 수초화를 촉진하기 위한 조성물 및 그의 용도
EP3737471A1 (en) 2018-01-11 2020-11-18 M Et P Pharma AG Treatment of demyelinating diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU1713151C (ru) * 1986-07-05 1995-02-09 Научно-производственное объединение "ВНИИ лекарственных и ароматических растений" Средство для лечения травматических и послеоперационных повреждений периферической нервной системы
RU2089610C1 (ru) * 1994-03-29 1997-09-10 Институт физиологии растений им.К.А.Тимирязева РАН Штамм культивируемых клеток растенийй stephania glabra (roxb) miers - продуцент стефарина
WO2003049761A1 (en) 2000-12-08 2003-06-19 Neuronz Limited Use of insuline-like growth factor-i for promoting remyelination of axons
AU2002363800A1 (en) * 2001-11-13 2003-05-26 Loi Tran Therapeutic agent composition and method of use

Also Published As

Publication number Publication date
PL2271340T3 (pl) 2012-09-28
DK2271340T3 (da) 2012-06-11
JP2011506316A (ja) 2011-03-03
WO2009075607A3 (en) 2009-10-29
CN101888842A (zh) 2010-11-17
CA2707681C (en) 2013-01-08
CA2707681A1 (en) 2009-06-18
KR20100113505A (ko) 2010-10-21
CN101888842B (zh) 2012-07-04
HRP20120422T1 (hr) 2012-06-30
EP2271340A2 (en) 2011-01-12
EA201000786A1 (ru) 2010-12-30
SI2271340T1 (sl) 2012-07-31
WO2009075607A2 (en) 2009-06-18
US20130226133A1 (en) 2013-08-29
ATE552001T1 (de) 2012-04-15
PT2271340E (pt) 2012-06-01
CY1112818T1 (el) 2016-02-10
RU2355413C1 (ru) 2009-05-20
US8440683B2 (en) 2013-05-14
JP5485166B2 (ja) 2014-05-07
EP2271340B1 (en) 2012-04-04
ES2383315T3 (es) 2012-06-20
US20100267756A1 (en) 2010-10-21

Similar Documents

Publication Publication Date Title
MX2010005642A (es) Preparados, metodos y estuches para el tratamiento de la tos.
GB2463833A (en) Methods and compositions for the treatment of neurological disorders
NZ593474A (en) Compositions and methods for treatment of celiac disease
MX2010005909A (es) Combinacion de inhibidores de fosfatasa de proteina tirosina y hormona de crecimiento humana para el tratamiento de atrofia muscular y trastornos relacionados.
MX341351B (es) Liberacion de adenosina basada en polimero de seda: potencial terapeutico para la epilepsia.
MX2010006519A (es) Metodo para tratar una fractura de hueso con anticuerpos anti-esclerostina.
WO2005102338A8 (en) Method of treating neuropathic pain using a crth2 receptor antagonist
MY161415A (en) A homeopathic formulation
WO2009038720A3 (en) Method and apparatus for applying light therapy
EA201000914A1 (ru) Новые терапевтические подходы в лечении смт и связанных с ней расстройств
BR112012021522A2 (pt) bráquete ortodôntico para um sistema ortodôntico, sistema de bráquete ortodôntico, kit ortodôntico, processo para fabricar um bráquete ortodôntico e método para tratar a mordida de um paciente humano
IL195256A0 (en) Compositions of r(+)and s(-)pramipexole and methods of using the same
WO2010135056A3 (en) Phimosis treatment device and method
MX2011012015A (es) Tratamiento de deterioro cognitivo leve y enfermedad de alzheimer.
EP1940515A4 (en) SYSTEM AND METHOD FOR CONFIGURING PATIENT DATA FOR RADIOTHERAPY TREATMENT
TW200733976A (en) Method for the treatment of cognitive dysfunction
MY177001A (en) Phenothiazine compounds for treating mild cognitive impairment
UA85471C2 (ru) Применение оксикодона для лечения висцеральной боли
WO2010071826A3 (en) Methods for treating osteoclast-related disease, compounds and compositions thereof
MX2009005725A (es) Metodos y composiciones para tratamiento y monitoreo de tratamiento de trastornos asociados con il-13.
SG10201405392RA (en) Method of treatment of neurodegenerative or neuro-muscular degenerative diseases andtherapeutic agent to treat the same
EP2461862A4 (en) SYSTEM AND METHOD FOR STIMULATION OF POSTERIOR TIBIAL NERVE AND / OR OTHER NERVE
PL379512A1 (pl) Nowe metody i ich zastosowanie
UA97875C2 (ru) Фармацевтическое средство для лечения демиелинизирующих заболеваний нервной системы на основе стефаглабрина
MX2011012538A (es) Terapia de combinacion para el tratamiento del mieloma multiple.